Status:
COMPLETED
DAHANCA 20 Palliative Radiotherapy for Head and Neck Cancer
Lead Sponsor:
University of Aarhus
Collaborating Sponsors:
Danish Head and Neck Cancer Group
Conditions:
Head and Neck Neoplasms
Recurrence
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
Palliative radiotherapy for head and neck cancer is widely used but the effect and side effects are largely unknown. We will study the effect of short hypofractionated palliative radiotherapy (20 Gy i...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Incurable primary or second primary head and neck cancer
- Speaks and reads Danish
- Capable of filling out questionnaires for at leas two months after radiotherapy
- Age\>=18 years
- Expected survival\> 3months
Exclusion
Key Trial Info
Start Date :
November 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2012
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00400426
Start Date
November 1 2006
End Date
June 1 2012
Last Update
June 19 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Oncology
Aarhus, Denmark, 8000 C